Rabinowicz Ron, Barchana Micha, Liphshiz Irena, Futerman Boris, Linn Shai, Weyl-Ben-Arush Myriam
Faculty of Medicine, Technion, Israel.
J Pediatr Hematol Oncol. 2012 Aug;34(6):421-9. doi: 10.1097/MPH.0b013e31826157ce.
Our goal was to describe childhood cancer incidence and survival in Israel and to identify demographic and epidemiologic variations among children and adolescents with cancer. We used data from the Israel National Cancer Registry to examine the incidence and survival of pediatric cancer in Israeli children aged 0 to 19 years, diagnosed during the years 1998 to 2007. Cases were analyzed according to sex, age, ethnicity, and geographic region. Among the 4255 cases of childhood cancer, there was a total age-adjusted incidence rate of 172.4 per million for children aged 0 to 19 years and 153.4 per million for children aged 0 to 14 years. The incidence rate for boys was higher than for girls (192.5 and 153.3, respectively) and higher for Jewish children than for Arab children (177.6 and 156.8, respectively). The largest groups were leukemias (22%), lymphomas (20.2%), and central nervous system tumors (17.4%). The number of new cases increased each year, but the incidence rate remained steady. The survival probability updated to December 2008 was estimated and the 5-year survival was calculated for the new cases until the end of 2003. The overall survival at 5 years was 80.8%, with 72.8% for the Arabic population and 83.2% for the Jewish population, and depended on the diagnosis. Incidence and survival in childhood cancer in Israel is at the same medium level compared with other parts of the world. This study may set the basis for investigating the genetic and environmental factors that cause pediatric cancer in Israel, delineating the genetic basis for ethnic origin disparities in survival.
我们的目标是描述以色列儿童癌症的发病率和生存率,并确定患癌儿童和青少年在人口统计学和流行病学方面的差异。我们使用了以色列国家癌症登记处的数据,来研究1998年至2007年期间确诊的0至19岁以色列儿童的儿童癌症发病率和生存率。根据性别、年龄、种族和地理区域对病例进行分析。在4255例儿童癌症病例中,0至19岁儿童的年龄调整后总发病率为每百万172.4例,0至14岁儿童为每百万153.4例。男孩的发病率高于女孩(分别为每百万192.5例和153.3例),犹太儿童的发病率高于阿拉伯儿童(分别为每百万177.6例和156.8例)。最大的类别是白血病(22%)、淋巴瘤(20.2%)和中枢神经系统肿瘤(17.4%)。新病例数量逐年增加,但发病率保持稳定。估计了截至2008年12月的生存概率,并计算了2003年底前新病例的5年生存率。5年总生存率为80.8%,阿拉伯人群为72.8%,犹太人群为83.2%,且取决于诊断结果。与世界其他地区相比,以色列儿童癌症的发病率和生存率处于中等水平。本研究可为调查以色列儿童癌症的遗传和环境因素奠定基础,阐明生存方面种族差异的遗传基础。